These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 14194933)

  • 1. [HYDANTOIN IN THE TREATMENT OF AMENORRHEA].
    KOREN Z
    Harefuah; 1964 Aug; 67():138-41. PubMed ID: 14194933
    [No Abstract]   [Full Text] [Related]  

  • 2. Spirodon (tetrantoin): a new anticonvulsant of the hydantoin group.
    PUTNAM TJ; JACOBS J
    Neurology; 1957 Nov; 7(11):784-8. PubMed ID: 13483836
    [No Abstract]   [Full Text] [Related]  

  • 3. The metabolic conversion of 3-methyl-5-ethyl-5-phenyl hydantoin (mesantoin) and of 5-ethyl-5-phenyl hydantoin (nirvanol) to 5 - ethyl -5- (p-hydroxyphenyl) hydantoin.
    BUTLER TC
    J Pharmacol Exp Ther; 1956 Jun; 117(2):160-5. PubMed ID: 13332557
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of hydantoin (mesantoin) as an anticonvulsive drug.
    HARRIS TH; OTTO JL
    Tex State J Med; 1947 Sep; 43(5):328-30. PubMed ID: 20261615
    [No Abstract]   [Full Text] [Related]  

  • 5. Ketogenic and other derivatives of hydantoin as anticonvulsants; further results.
    ORDWAY GL; PURO HE
    Stanford Med Bull; 1949 Nov; 7(4):157. PubMed ID: 15394886
    [No Abstract]   [Full Text] [Related]  

  • 6. [Value of 3-methyl-5, 5-phenyl-ethyl-hydantoin in therapy of epilepsy].
    HOLTZER PA
    Belg Tijdschr Geneesk; 1952 Sep; 8(18):817-31. PubMed ID: 13008950
    [No Abstract]   [Full Text] [Related]  

  • 7. The metabolic fate of 5-ethyl-1-methyl-5-phenyl hydantoin (1-methylnirvanol) and that of 3,5-diethyl-5-phenyl hydantoin (3-ethylnirvanol).
    BUTLER TC; WADDELL WJ
    J Pharmacol Exp Ther; 1959 Nov; 127():171-4. PubMed ID: 13806515
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of epilepsy with hydantoin preparations].
    JANZ D
    Nervenarzt; 1950 Mar; 21(3):113-9. PubMed ID: 15423634
    [No Abstract]   [Full Text] [Related]  

  • 9. Epilepsy; treatment with new drug; 3-methyl 5,5-phenyl-ethyl-hydantoin (phenantoin).
    KOZOL HL
    Am J Psychiatry; 1946 Sep; 103(2):154-8. PubMed ID: 21001983
    [No Abstract]   [Full Text] [Related]  

  • 10. [USE OF A BROMATED HYDANTOIN IN THE TREATMENT OF DISORDERS OF MENOPAUSE].
    FIZ G
    J Med Bord; 1964 Jan; 141():79-86. PubMed ID: 14128348
    [No Abstract]   [Full Text] [Related]  

  • 11. [Dimethyl-dithio-hydantoin therapy in essential facial neuralgia].
    Med Hyg (Geneve); 1951 Mar; 9(189):82. PubMed ID: 14826106
    [No Abstract]   [Full Text] [Related]  

  • 12. [Essential facial neuralgia therapy with dimethyl-dithio-hydantoin].
    LEMOYNE J
    Concours Med; 1951 Feb; 73(6):461-3. PubMed ID: 14812778
    [No Abstract]   [Full Text] [Related]  

  • 13. Methyl-phenyl-ethyl hydantoin in the treatment of convulsive disorders.
    MARSH C; MILLER VJ
    Bull Los Angel Neuro Soc; 1949 Dec; 14(4):227-31. PubMed ID: 15406178
    [No Abstract]   [Full Text] [Related]  

  • 14. [A case of erythema exudativum multiforme associated with hydantoin treatment].
    MUNZI G; VARVERI A
    Arch Ital Pediatr Pueric; 1962 Oct; 22():326-31. PubMed ID: 13936683
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hydantoin therapy in epilepsy].
    STRAUCH W
    Dtsch Gesundheitsw; 1953 May; 8(20):591-601. PubMed ID: 13067813
    [No Abstract]   [Full Text] [Related]  

  • 16. [A new anti-epileptic: dimethyl-dithio-hydantoin].
    LAPLANE R; DEBRAY P
    Arch Fr Pediatr; 1950; 7(5):527-9. PubMed ID: 14783460
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of dimethyl-dithio-hydantoin in treatment of certain facial neuralgias].
    LEMOYNE J
    Ann Otolaryngol; 1950; 67(8-9):626-8. PubMed ID: 14790443
    [No Abstract]   [Full Text] [Related]  

  • 18. The alkaline hydrolysis of fluorenone-spiro-hydantoin.
    HARRIS GH; HARRIMAN BR; WHEELER KW
    J Am Chem Soc; 1946 May; 68():846-8. PubMed ID: 21024890
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical evaluation of 1-methyl-5,5-phenyl-ethyl-hydantoin in the treatment of epilepsy.
    LIVINGSTON S; PAULI LL; KRAMER I; NAJMABADI A
    N Engl J Med; 1961 Aug; 265():418-21. PubMed ID: 13762831
    [No Abstract]   [Full Text] [Related]  

  • 20. Pyrrole formation during attempted hydantoin synthesis.
    HENZE HR; SHOWN JH
    J Am Chem Soc; 1947 Jul; 69(7):1662-6. PubMed ID: 20251398
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.